首页|期刊导航|肿瘤学与转化医学(英文)|CD14 macrophage and IL-10 levels in the peripheral blood of breast cancer patients and their diagnostic value

CD14 macrophage and IL-10 levels in the peripheral blood of breast cancer patients and their diagnostic valueOA

CD14 macrophage and IL-10 levels in the peripheral blood of breast cancer patients and their diagnostic value

Mengting Dong;Jiayu Sheng;Chunyang Li;Patiguli·JIAPAER;Xiaofei Li;Minjia Yuan;Xiaohong Xue;Ke Jiang

Department of Breast Diseases,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,ChinaDepartment of Breast Diseases,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,ChinaDepartment of Breast Diseases,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,ChinaDepartment of Breast Diseases,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,ChinaDepartment of Breast Diseases,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,ChinaDepartment of Breast Diseases,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,ChinaDepartment of Breast Diseases,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,ChinaDepartment of Breast Diseases,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China

breast cancermacrophageIL-10peripheral blooddiagnostic value

breast cancermacrophageIL-10peripheral blooddiagnostic value

《肿瘤学与转化医学(英文)》 2022 (4)

“芪术方”通过APOC3-TLR2配受体对调控巨噬细胞自噬介导的M2极化阻止三阴性乳腺癌免疫逃逸机制研究

165-172,8

Supported by grants from the National Natural Science Foundation of China(No.82104952,No.82004240),Special project for clinical research of health industry of Shanghai Municipal Health Commission(No.202140172),Special project of medical innovation research of Shanghai Science and Technology Commission(No.21Y11923600)and the Shanghai Office of Traditional Chinese Medicine Development(No.ZY2018-2020-RCPY-2009).

10.1007/s10330-021-0539-9

评论

您当前未登录!去登录点击加载更多...